Author

Chrysa Papagianni

The Netherlands Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Matheus Henrique DiasiD· 1 shared René BernardsiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Matheus Henrique DiasORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PEBP1 is a candidate biomarker of response to the PP2A inhibitor LB-100

Matheus Henrique Dias, Chrysa Papagianni, René Bernards

This study identifies PEBP1 as a biomarker for response to the PP2A inhibitor LB-100, showing that its depletion confers resistance by reducing prodrug conversion to the active metabolite endothall.

bioRxiv · Feb 25, 2025 · PreprintCancer Biology